Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case–Control Study
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Grzegorz K. Jakubiak & Natalia Pawlas & Grzegorz Cieślar & Agata Stanek, 2021. "Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes," IJERPH, MDPI, vol. 18(22), pages 1-23, November.
- Chan Hyuk Park & Eun Hye Kim & Yun Ho Roh & Ha Yan Kim & Sang Kil Lee, 2014. "The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 9(11), pages 1-8, November.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Bin Xia & Qiangsheng He & Fang Gao Smith & V. Georgios Gkoutos & Krishnarajah Nirantharakumar & Zi Chong Kuo & Danni Wang & Qi Feng & Eddie C. Cheung & Lunzhi Dai & Junjie Huang & Yuanyuan Yu & Wenbo , 2024. "Individualized prevention of proton pump inhibitor related adverse events by risk stratification," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Vicente Pallarés-Carratalá & Vivencio Barrios & David Fierro-González & Jose Polo-García & Sergio Cinza-Sanjurjo, 2023. "Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study," IJERPH, MDPI, vol. 20(3), pages 1-11, January.
- Alexandru Achim & Agata Stanek & Călin Homorodean & Mihail Spinu & Horea Laurenţiu Onea & Leontin Lazăr & Mădălin Marc & Zoltán Ruzsa & Dan Mircea Olinic, 2022. "Approaches to Peripheral Artery Disease in Diabetes: Are There Any Differences?," IJERPH, MDPI, vol. 19(16), pages 1-11, August.
- Szymon Mućka & Martyna Miodońska & Grzegorz K. Jakubiak & Monika Starzak & Grzegorz Cieślar & Agata Stanek, 2022. "Endothelial Function Assessment by Flow-Mediated Dilation Method: A Valuable Tool in the Evaluation of the Cardiovascular System," IJERPH, MDPI, vol. 19(18), pages 1-16, September.
- Kyoung-Hee Cho & Juyeong Kim & Young Choi & Tae-Hyun Kim, 2022. "The Effect of Neighborhood Deprivation on Mortality in Newly Diagnosed Diabetes Patients: A Countrywide Population-Based Korean Retrospective Cohort Study, 2002–2013," IJERPH, MDPI, vol. 19(7), pages 1-14, April.
- Marek Zak & Tomasz Sikorski & Magdalena Wasik & Daniel Courteix & Frederic Dutheil & Waldemar Brola, 2022. "Frailty Syndrome—Fall Risk and Rehabilitation Management Aided by Virtual Reality (VR) Technology Solutions: A Narrative Review of the Current Literature," IJERPH, MDPI, vol. 19(5), pages 1-12, March.
- Xunjie Cheng & Tianqi Ma & Feiyun Ouyang & Guogang Zhang & Yongping Bai, 2022. "Trends in the Prevalence of Cardiometabolic Multimorbidity in the United States, 1999–2018," IJERPH, MDPI, vol. 19(8), pages 1-12, April.
- Piotr Rola & Jan Jakub Kulczycki & Adrian Włodarczak & Mateusz Barycki & Szymon Włodarczak & Marek Szudrowicz & Łukasz Furtan & Artur Jastrzębski & Maciej Pęcherzewski & Maciej Lesiak & Adrian Doroszk, 2022. "Intravascular Lithotripsy as a Novel Treatment Method for Calcified Unprotected Left Main Diseases—Comparison to Rotational Atherectomy—Short-Term Outcomes," IJERPH, MDPI, vol. 19(15), pages 1-12, July.
- Monika Starzak & Agata Stanek & Grzegorz K. Jakubiak & Armand Cholewka & Grzegorz Cieślar, 2022. "Arterial Stiffness Assessment by Pulse Wave Velocity in Patients with Metabolic Syndrome and Its Components: Is It a Useful Tool in Clinical Practice?," IJERPH, MDPI, vol. 19(16), pages 1-14, August.
- Chen-Chih Chu & Yong-Chen Chen & Ming-Hsun Lin & Wen-Tung Wu & Feng-Cheng Liu & Hsiang-Cheng Chen & Yu-Ching Chou & Chien-An Sun, 2022. "Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study," IJERPH, MDPI, vol. 19(6), pages 1-9, March.
More about this item
Keywords
proton pump inhibitors; type 2 diabetes mellitus; upper gastrointestinal disease;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:14:p:8739-:d:865384. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.